Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $26
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $26.
Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $26.